SPEAKING & ENGAGEMENTS
Ideas build industries.
Infrastructure makes them real.
Keynotes and executive sessions where biotechnology, intelligent machines, photonics, bio-cybersecurity, venture capital, and the architecture of real-world execution intersect.
A systems-level view of what comes next.
Jay Berube is the founder and CEO of Berube BioVentures and founder of CDMO Network™, a platform connecting scientific development with biomanufacturing capabilities and commercial execution.
His career crosses biological sciences, precision optics, photonics, industrial technology, venture development, applied AI, and digital infrastructure. His talks connect the long view to the hard constraints: what can be built, measured, funded, protected, and made to work. A promising idea becomes consequential when its science, people, capital, and execution align.
Explore published perspectivesSpeaking subjects.
Choose one field or combine several. Every session is shaped around the audience, the real constraint, and the next consequential decision.
Science Does Not Scale Itself
From discovery to GMP: the manufacturing decisions behind mRNA/LNP therapies, recombinant proteins, live biotherapeutics, phages, and other emerging modalities.
The Future of Biomanufacturing Is a Network
Why fragmented CDMO capabilities demand neutral routing, technical qualification, market intelligence, and disciplined sponsor-to-manufacturer handoffs.
AI as the Operating Layer of Business
Using AI to sharpen brands, build websites, improve marketing and search visibility, discover customers, qualify opportunities, and develop intelligent business workflows.
Securing Biology's Digital Future
Genomic and biomarker information, scientific intellectual property, encrypted data ecosystems, and the emerging security requirements of connected life sciences.
The Next Era of Animal Health Manufacturing
Veterinary vaccines, recombinant proteins, VHHs, mRNA technologies, and companion-animal therapeutics—and the manufacturing infrastructure needed to commercialize them.
Ecosystems Are the New Enterprises
Building cross-industry ventures by connecting scientific capabilities, technology, capital, commercial partnerships, and investment strategy.
From Fantasy to Factory
Starting with a vision, brand, AI-enabled prototype, and market feedback—then developing the technical roadmap, capital, organization, and physical infrastructure that give the vision form.
The Handoff Decides the Race
Lessons from competitive athletics and commercial leadership about trust, timing, momentum, and transferring responsibility without losing execution speed.
The Dream Needs a Body
Vision, creative architecture, and the transformation of abstract ideas into institutions with real-world consequence.
Sales Beyond the Close
Close enough to act. Open enough to become. A new approach to complex B2B sales built on curiosity, reciprocal disclosure, strategic questioning, and turning trust into measurable commercial action.
The Architecture of an Investable Company
What transforms a promising idea into an investable business? Connecting scientific validation, commercial demand, leadership, manufacturing readiness, and capital strategy into one credible venture architecture.
The Topology of Opportunity
Your career is the network you learn to build. Discover how cross-industry relationships, transferable capabilities, and shared language create professional opportunities beyond conventional organizational structures.
Build a Company Talent Wants to Find.
The strongest organizations attract people before they recruit them. Cultivate compelling missions, credible culture, meaningful professional networks, and opportunities that draw exceptional people together.
Grow a Company Like a Garden.
The art of growth is cultivating what can become. Explore stewardship, adaptation, organizational roots, and the conditions through which teams, partnerships, and innovations flourish together.
From Molecule to Mind: The Future of Psychedelic Medicine.
Explore the scientific and industrial pathway for investigational psychedelic therapeutics, including psilocybin, pharmaceutical manufacturing, formulation, clinical development, regulation, and commercialization.
Markets Merging: The New Frontier of Biology, Defense & Space
Biotechnology, photonics, advanced materials, aerospace, and defense are converging into new industrial and investment markets. Examine transferable technologies, qualification barriers, strategic partnerships, and the capital required to move breakthrough capabilities between industries.
Dream Manifest: When Intelligence Acquires a Body
AI is moving beyond screens into machines that sense, navigate, manipulate, and act. Explore robotics, neuromorphic computing, edge intelligence, autonomous laboratories, and the difficult work of transforming intelligent prototypes into reliable physical products.
The Physics of Perception: From Photons to Intelligent Machines
From autonomous vehicles to molecular diagnostics, reliable perception begins with physics. Trace the convergence of optical calibration, nanotextures, lasers, sensors, and biophotonics—and the manufacturing and investment pathways that bring them to market.
Hybrid Merge.
The next market is often hidden in the space between two that already exist.
Choose any two of the eighteen subjects—or arrive with a question that refuses to belong to one industry. A laboratory needs secure intelligence. A robot needs calibrated perception and a body that performs. Aerospace and medicine draw on the same optics, advanced materials, and manufacturing disciplines. Each overlap changes what is technically possible, what can be financed, and who needs to work together.
We can build a bespoke keynote, executive session, or strategic workshop around those intersections: from Dream to engineering, from scientific capability to commercial architecture, from capital to the difficult work of execution. The objective is a larger way of seeing, followed by a sharper plan for acting.
From the keynote stage to the boardroom.
Invite Jay to speak.
For conference organizers, corporations, universities, professional associations, and event producers.
In-person and virtual engagements are considered in the United States and internationally. Speaking fees and travel arrangements are discussed individually.